#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Myeloproliferative neoplasm Severe myoclonic epilepsy of infancy Medullary thyroid cancer ABO haemolytic disease of newborn Stargardt's disease Craniopharyngioma Pulmonary fibrosis Uveitis Langerhans cell sarcoma Short stature homeobox gene mutation Cervix carcinoma Oesophageal adenocarcinoma stage III Osteosarcoma recurrent Transferrin decreased Fatty acid oxidation disorder More trials…

    Learn about Rare Diseases

    Short-bowel syndrome – Diagnostics Acquired haemophilia – Life with Disease Osteosarcoma – Basic Information Lysosomal storage disorder – Diagnostics Osteosarcoma recurrent – Basic Information KBG syndrome – Treatment Hereditary neuropathic amyloidosis – Trials in Disease Hereditary optic atrophy – Basic Information Langerhans’ cell histiocytosis – Life with Disease Phenylketonuria More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    MB-HUCART19.1 A52 Depemokimab Teriflunomide Formoterol Fumarate Pantothenate Sodium Bdc-1001 AUR200 Mosunetuzumab Cabozantinib APROTININ Azithromycin Desloratadine Fondaparinux Sodium Celecoxib Ascorbic Acid Amitriptyline Zidovudine Adrenaline Acid Tartrate Bp Art0380 Mesilate More therapies…

    Learn about Your Condition

    Radicular pain Colorectal adenoma Immune thrombocytopenia Pituitary tumour benign Lysosomal storage disorder Neck pain Pancreatic fistula Gout Alveolar rhabdomyosarcoma Kaposi's sarcoma Colon cancer metastatic Ocular lymphoma Alpha-1 antitrypsin deficiency Cholangiocarcinoma Femur fracture More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Skin and Connective Tissue Diseases

  • Study on Atopic Dermatitis Treatment with Baricitinib, Tralokinumab, Abrocitinib, Upadacitinib, and Dupilumab for Patients Needing Second-Line Systemic Therapy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Dermatitis atopic
    Investigated Drugs:
    • Abrocitinib
    • Tralokinumab
    • Baricitinib
    Spain

  • Study on the Effect of Dexamethasone and Betamethasone Sodium Phosphate on Leg Swelling in Patients Undergoing Total Hip Replacement

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Betamethasone Sodium Phosphate
    Spain

  • Study on Hydroxychloroquine for Patients with Cutaneous Mastocytosis or Indolent Systemic Mastocytosis with Skin Involvement

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Mastocytosis
    Investigated Drugs:
    • Hydroxychloroquine Sulfate
    France

  • Study on Mesenchymal Stem Cells for Patients with Systemic Sclerosis and Digital Ulcers

    Recruiting

    2 1
    Investigated Diseases:
    • Systemic scleroderma
    Investigated Drugs:
    • Human Mesenchymal Stem Cells
    The Netherlands

  • ICP-332 for Adults with Prurigo Nodularis

    Recruiting

    2 1
    Investigated Diseases:
    • Neurodermatitis
    Austria Belgium France Germany Poland

  • A study to evaluate the long-term safety and effectiveness of afimkibart in patients with atopic dermatitis who took part in previous afimkibart studies

    Recruiting

    2 1
    Investigated Drugs:
    • Ro7790121
    France Germany Italy Poland Spain
Previous Page
1 … 19 20 21 22 23 … 66
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!